Tadalafil for veterans with chronic obstructive pulmonary disease—pulmonary hypertension: A multicenter, placebo‐controlled randomized trial
Abstract Treating Veterans with chronic obstructive pulmonary disease complicated by pulmonary hypertension (COPD‐PH) using phosphodiesterase type‐5 inhibitor pharmacotherapy is common, but efficacy data are lacking. To address this further, patients with COPD‐PH from five Department of Veterans Aff...
Main Authors: | Bradley A. Maron, Gaurav Choudhary, Rebekah L. Goldstein, Eric Garshick, Matthew Jankowich, Troo J. S. Tucker, Kathleen A. LaCerda, Brack Hattler, Edward C. Dempsey, Ruxana T. Sadikot, Shelley Shapiro, Sharon I. Rounds, Ronald H. Goldstein |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Pulmonary Circulation |
Subjects: | |
Online Access: | https://doi.org/10.1002/pul2.12043 |
Similar Items
-
Echocardiographic predictors of mortality in patients with pulmonary hypertension and cardiopulmonary comorbidities.
by: Johannes Steiner, et al.
Published: (2015-01-01) -
Bacterial Infections Associated with Immunosuppressive Agents Commonly Used in Patients with Interstitial Lung Diseases
by: Said Chaaban, et al.
Published: (2023-03-01) -
Socioeconomically disadvantaged veterans experience treatment delays for pulmonary arterial hypertension
by: Kari R. Gillmeyer, et al.
Published: (2022-10-01) -
Cough Assessment and Management in Pulmonary Rehabilitation– A Canadian Survey
by: Ana Maria Ilicic, et al.
Published: (2023-12-01) -
Pulmonary rehabilitation: an integral part of the long-term management of COPD
by: Y Lacasse, et al.
Published: (2004-10-01)